GILL PHARMA CONSULT LIMITED
Significant control: Aaron Singh Gill (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Gill Pharma Consult Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Gill Pharma Consult Limited sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GILL PHARMA CONSULT LIMITED is an active private limited company (company number 15723977) incorporated on 16 May 2024, registered in London. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 31 May 2026, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
There are 7,601 companies in other professional, scientific and technical activities n.e.c. in London with filed accounts; the median reports net assets of £3,258 and is 9 years old.
Ownership and control
- Aaron Singh Gill
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 May 20242 yrs ago
- Next accounts due
- 29 February 2028in 491 days
- Confirmation statement due
- 30 May 2027in 216 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | — | — | — | £33k | — | — | 1 |
| 31 May 2025 | — | — | — | £39k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.07
- Incorporated two to five years agoIncorporated 16 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 491 days
- Confirmation statement duein 216 days
- Accounts period end
- Accounts period end
- Incorporated
Similar companies in London
- EJ CAPITAL SERVICES LIMITEDLondon · inc. May 2024
- POLLEN MADDOX LIMITEDLondon · inc. May 2024
- FIRE & FACADE ENGINEERING LTDLondon · inc. May 2024
- EVERSHOT RESEARCH LTDLondon · inc. May 2024
- LQX EDUCATION LTDLondon · inc. May 2024
- KSL CAPITAL PARTNERS (UK) LTDLondon · inc. May 2024
All companies incorporated on 16 May 2024 · in May 2024.
Reminders for GILL PHARMA CONSULT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.